In total , @ postmenopausal women were included in this double-blind , randomized clinical trial and divided into three groups : Group A used estrogen therapy alone ( @ mg of @-estradiol ) , Group B received estrogen-progestin therapy ( @ mg of @ - estradiol +@ mg of norethisterone acetate ) and Group C received a placebo ( control ) .